The pharmaceutical industry has become a significant engine for growth in major economies that have developed their own business fabric, being, in some cases, the industry with the greatest level of investment in R&D and one that contributes significantly to the creation of employment (both direct and indirect). This has been amplified by the pandemic, with the industry demonstrating unprecedented responsiveness
The industry is currently facing major challenges such as ensuring regulatory compliance in a context of intense regulation, competition in the global market but with the need to adapt to local specificities, the incorporation of sustainability as a key element in processes involving the research, production, storage and distribution of medicines, the use of new technologies (Big Data, Artificial Intelligence, etc.), the adaptation to new organizational and working models to increase profitability and efficiency levels, both operational and commercial, and implement comprehensive and appropriate risk management (e.g., considering risks from the point of view of operational and commercial efficiency), the adaptation to new organizational and working models to increase profitability and efficiency levels, both operational and commercial, and implement comprehensive and adequate risk management (e.g., considering risks from a reputational point of view), in addition to establishing robust plans to ensure the continuity of operations.
Our practice
The Management Solutions catalog of solutions is perfectly adapted to the particularities of the pharmaceutical industry. We are capable of applying advanced modeling and data treatment techniques, defining and implementing information governance mechanisms and data quality, optimizing and anticipating processes, evolving the risk function of companies (maps, appetite, integration, etc. ) or to help companies to redefine their HR strategies, corporate functions and efficiency plans, or Agile transformation.
